Sector ratings Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:03 2026-08-21 pm EDT
|
5-day change | 1st Jan Change | ||
| 295.19 USD | +1.28% |
|
+4.95% | +47.98% |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 13.91B | AA | |||||||
| 51.22B | AAA | |||||||
| 45.38B | - | B | - | - | ||||
| 41.97B | - | |||||||
| 42.15B | AAA | |||||||
| 31.95B | A | |||||||
| 16.73B | - | - | - | - | ||||
| 17.1B | BBB | |||||||
| 14.76B | AA | |||||||
| 13.45B | AAA | |||||||
| 12.73B | AA | |||||||
| 11.26B | AA | |||||||
| 12.03B | A | - | ||||||
| 10.18B | - | B | - | - | ||||
| 10.1B | - | BBB | - | - | ||||
| 10.95B | - | BBB | - | - | ||||
| 10.16B | - | B | - | - | ||||
| 9.76B | - | A | - | - | ||||
| 9.75B | BB | - | ||||||
| 9.16B | - | BB | - | - | ||||
| Average | 19.74B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
